MSN Laboratories today announced the launch of SEMABEST, its semaglutide brand, in the Indian market following approval from the Central Drugs Standard Control Organisation (CDSCO). ... Apr 15
FDA-approved injectables adds credibility in Africa, Latin America, and beyond. The ripple effect may elevate Indian pharmaceutical manufacturing from “copycat” to “crown-standard.”... Aug 16
Rivaroxaban under a generic label can significantly reduce treatment costs for patients, insurers, and government healthcare programs, all while maintaining the efficacy and safety standards ... Jun 03
A study on the public health and socioeconomic impact of substandard and falsified medical products, showed that 10% of medical products in low- and middle-... Mar 19
Glenmark has launched Tiotropium Bromide Dry Powder Inhaler (DPI) under the brand name - Tiogiva in UK ... Jun 15
... Feb 24
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Truvada Tablets, 200 mg/300 mg, of Gilead Sciences... Jan 15
The medication is used to treat overactive bladder and urinary conditions... Dec 18
... Nov 23
US FDA approval for Granules India... Dec 26
-Advertisements-